elara glp-1 π GLP-1s aren't magic wandsβ¦ they're a tool π§° There's a lot of noise out there about medications β and one of the biggest misconceptions? That the injection alone is the ECL x GLP-1 Up
Description
1994;59:747S752S

Eli Lillys Zepbound produced average weight loss of 22.5 percent in trials, and its next-generation injection, retatrutide, pushed that even higher
The concrete figure in the release: a 2.2% reduction in HbA1c at week 28 with berobenatide 1.6 mg weekly (on-treatment estimand), versus a 0.2% reduction in the placebo group
The half-life for liraglutide is about 1014 h in humans (Agerso et al., 2005

1-4 It belongs to the drug class of glucagon-like peptide-1 (GLP-1) receptor agonists
